206 related articles for article (PubMed ID: 21499703)
1. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Sugano K; Matsumoto Y; Itabashi T; Abe S; Sakaki N; Ashida K; Mizokami Y; Chiba T; Matsui S; Kanto T; Shimada K; Uchiyama S; Uemura N; Hiramatsu N
J Gastroenterol; 2011 Jun; 46(6):724-35. PubMed ID: 21499703
[TBL] [Abstract][Full Text] [Related]
2. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Sugano K; Kontani T; Katsuo S; Takei Y; Sakaki N; Ashida K; Mizokami Y; Asaka M; Matsui S; Kanto T; Soen S; Takeuchi T; Hiraishi H; Hiramatsu N
J Gastroenterol; 2012 May; 47(5):540-52. PubMed ID: 22388884
[TBL] [Abstract][Full Text] [Related]
3. Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.
Sanuki T; Fujita T; Kutsumi H; Hayakumo T; Yoshida S; Inokuchi H; Murakami M; Matsubara Y; Kuwayama H; Kawai T; Miyaji H; Fujisawa T; Terao S; Yamazaki Y; Azuma T;
J Gastroenterol; 2012 Nov; 47(11):1186-97. PubMed ID: 22526273
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.
Sakaki N; Ashida K; Mizokami Y; Chiba T; Matsui S; Kanto T; Uemura N; Hiramatsu N; Sugano K
Hepatogastroenterology; 2013 Jun; 60(124):762-7. PubMed ID: 23478070
[TBL] [Abstract][Full Text] [Related]
5. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin.
Iwakiri R; Higuchi K; Kato M; Fujishiro M; Kinoshita Y; Watanabe T; Takeuchi T; Yamauchi M; Sanomura M; Nakagawa H; Sugisaki N; Okada Y; Ogawa H; Arakawa T; Fujimoto K
Aliment Pharmacol Ther; 2014 Oct; 40(7):780-95. PubMed ID: 25100080
[TBL] [Abstract][Full Text] [Related]
7. Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.
Kawai T; Oda K; Funao N; Nishimura A; Matsumoto Y; Mizokami Y; Ashida K; Sugano K
Gut; 2018 Jun; 67(6):1033-1041. PubMed ID: 29196436
[TBL] [Abstract][Full Text] [Related]
8. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
Graham DY; Agrawal NM; Campbell DR; Haber MM; Collis C; Lukasik NL; Huang B;
Arch Intern Med; 2002 Jan; 162(2):169-75. PubMed ID: 11802750
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
10. Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial.
Wong GLH; Lau LHS; Ching JYL; Tse YK; Ling RHY; Wong VWS; Chiu PWY; Lau JYW; Chan FKL
Gut; 2020 Apr; 69(4):652-657. PubMed ID: 31229990
[TBL] [Abstract][Full Text] [Related]
11. Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.
Sugano K; Choi MG; Lin JT; Goto S; Okada Y; Kinoshita Y; Miwa H; Chiang CE; Chiba T; Hori M; Fukushima Y; Kim HS; Chang CY; Date M;
Gut; 2014 Jul; 63(7):1061-8. PubMed ID: 24326741
[TBL] [Abstract][Full Text] [Related]
12. Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers.
Kawamura N; Ito Y; Sasaki M; Iida A; Mizuno M; Ogasawara N; Funaki Y; Kasugai K
BMC Res Notes; 2013 Nov; 6():455. PubMed ID: 24215903
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
Bianchi Porro G; Lazzaroni M; Imbesi V; Montrone F; Santagada T
Dig Liver Dis; 2000 Apr; 32(3):201-8. PubMed ID: 10975769
[TBL] [Abstract][Full Text] [Related]
14. Lansoprazole versus omeprazole for duodenal ulcer healing and prevention of relapse: a randomized, multicenter, double-masked trial.
Dobrilla G; Piazzi L; Fiocca R
Clin Ther; 1999 Aug; 21(8):1321-32. PubMed ID: 10485504
[TBL] [Abstract][Full Text] [Related]
15. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
16. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
Raskin JB; White RH; Jackson JE; Weaver AL; Tindall EA; Lies RB; Stanton DS
Ann Intern Med; 1995 Sep; 123(5):344-50. PubMed ID: 7625622
[TBL] [Abstract][Full Text] [Related]
17. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
Lai KC; Lam SK; Chu KM; Wong BC; Hui WM; Hu WH; Lau GK; Wong WM; Yuen MF; Chan AO; Lai CL; Wong J
N Engl J Med; 2002 Jun; 346(26):2033-8. PubMed ID: 12087138
[TBL] [Abstract][Full Text] [Related]
19. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
20. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
Goldstein JL; Scheiman JM; Fort JG; Whellan DJ
J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]